<DOC>
	<DOCNO>NCT00321321</DOCNO>
	<brief_summary>The investigator hypothesize impaired insulinotropic effect incretin hormone GIP may due inadequate sensitization ATP induce closure beta cell K-ATP channel . By close channel use sulfonylurea ( SU ) hope restore insulinotropic effect GIP .</brief_summary>
	<brief_title>The Beta Cell Responsiveness Glucose-dependent Insulinotropic Polypeptide ( GIP ) With Without Sulfonylurea Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<criteria>Type 2 diabetes mellitus diagnose accord WHO criteria Diet and/or metformin treatment HbA1c &gt; 7,0 % metformin treat patient HbA1c &gt; 7,5 % diet treated patient Age : 18 year old 25 &gt; BMI &gt; 40 kg/m2 Signed informed consent Sufficient birth control case child bear capacity Proliferative retinopathy Diabetic nephropathy screatinine &gt; 130 microM and/or macroalbuminuria Liver disease ( ALAT &gt; 2 x normal value ) CAD ( NYHA group III IV ) Positive screen isletcell and/or GAD65 autoantibody Type 1 diabetes first degree relative Gastrointestinal surgery intestinal resection Anemia Pregnancy and/or breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Glucose dependent insulinotropic polypeptide</keyword>
	<keyword>Sulfonylurea compound</keyword>
	<keyword>insulin secretion</keyword>
	<keyword>Sulfonylurea receptor subunit-SUR1</keyword>
	<keyword>Impaired incretin effect</keyword>
</DOC>